Trial Profile

Phase I Trial to Assess the Safety and Pharmacokinetics of a Single Ascending Dose (SAD) of N-Methanocarbathymidine (N-MCT) in Normal Volunteers

Status: Active, no longer recruiting

Phase of Trial: Phase I

Latest Information Update: 10 Sep 2018

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs N Methanocarbathymidine (Primary)
Indications Herpes zoster
Focus Adverse reactions
Sponsors N&N Pharmaceuticals

Most Recent Events

21 Sep 2016 Planned primary completion date changed from 1 Aug 2016 to 1 Dec 2016.
21 Sep 2016 Status changed from recruiting to active, no longer recruiting.
22 Apr 2016 According to N&N Pharmaceuticals media release, these trials will be conducted in at Georgetown University Hospital, Division of Infectious Diseases and Dr. Princy Kumar will serve as Principal Clinician during this period.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com